A clinical trial is the sole way that new medicines come to market. Mastering the process of finding, engaging, and activating patients for enrollment into a clinical trial is a key success factor for all biopharmaceutical…
Revenue management systems hold valuable data with tremendous potential to provide business insights. Unfortunately, the power of this data is often locked behind technology barriers and reporting roadblocks such as: Data and analytics sourced from multiple…
Launching a product is a serious undertaking, requiring a seamless approach to building a commercialisation strategy that includes all the variables needed to maximise the investment across the product’s lifecycle. Nowhere is this more true than…
Q. How do you successfully commercialize a new product in the new era of “patient-as-consumer” and “outcomes-based healthcare”? A. You design and deliver an engaging, high-touch patient experience. In this 30 minute webinar, Tom Doyle explains…
The industry’s shift to outcomes-based, patient-centered care requires new approaches to patient support to achieve adherence and therapeutic success. Today’s patients are also highly motivated information seekers and are taking control of their day-to-day therapy. And,…
2020 promises to be eye-opening as the coming election will surely provide clarity to the path that we will be taking for oncology treatment access. From international reference pricing, acceleration of biosimilars and generics, and allowance…
A Seat of Influence. Patients rely on us not only to develop life-saving therapies, but also for help in developing strategies to ensure that they can access those therapies. The role of the Chief Patient Officer…
[Webinar: 23 Minutes] With over 20 years experience on the clinical research arena, Mike Ryan shares the importance of patient engagement from the clinical trial all the way across the drug development continuum. He highlights that…
For the past several years, the pharmaceutical industry has focused on exploring and establishing value-based contracts (VBCs) between manufacturers and their customers. In these arrangements, payments are predicated upon measurements of patient welfare, rather than formulary…
“Alexa…,” “Hey Siri…,” “OK Google…,” “Hey Cortana…,” and “Hi Bixby….” These are the now-familiar “wake words” that we use to interact with our digital assistants and an ever-growing number of smart speakers. Chances are you have even…
[Presentation Slides] The advancements of Digital Therapies are promising but commercial success is not always guaranteed. This presentation by Jonathan Hodgson will explore the pitfalls and challenges of selling products into the uniquely complicated and regulated healthcare…